Penumbra (PEN) Competitors $281.04 -0.52 (-0.18%) As of 05/20/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PEN vs. GEHC, PHG, ZBH, SOLV, SNN, STVN, GKOS, NARI, INSP, and IRTCShould you be buying Penumbra stock or one of its competitors? The main competitors of Penumbra include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Solventum (SOLV), Smith & Nephew (SNN), Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), and iRhythm Technologies (IRTC). These companies are all part of the "medical equipment" industry. Penumbra vs. GE HealthCare Technologies Koninklijke Philips Zimmer Biomet Solventum Smith & Nephew Stevanato Group Glaukos Inari Medical Inspire Medical Systems iRhythm Technologies Penumbra (NYSE:PEN) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, valuation, profitability, media sentiment, analyst recommendations, earnings, institutional ownership and dividends. Is PEN or GEHC more profitable? GE HealthCare Technologies has a net margin of 10.13% compared to Penumbra's net margin of 1.17%. GE HealthCare Technologies' return on equity of 25.74% beat Penumbra's return on equity.Company Net Margins Return on Equity Return on Assets Penumbra1.17% 9.74% 7.35% GE HealthCare Technologies 10.13%25.74%6.29% Does the media prefer PEN or GEHC? In the previous week, GE HealthCare Technologies had 3 more articles in the media than Penumbra. MarketBeat recorded 23 mentions for GE HealthCare Technologies and 20 mentions for Penumbra. GE HealthCare Technologies' average media sentiment score of 1.52 beat Penumbra's score of 1.08 indicating that GE HealthCare Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Penumbra 14 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GE HealthCare Technologies 22 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has preferable earnings and valuation, PEN or GEHC? GE HealthCare Technologies has higher revenue and earnings than Penumbra. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPenumbra$1.24B8.78$90.95M$1.06265.13GE HealthCare Technologies$19.80B1.66$1.99B$4.7515.13 Do insiders & institutionals have more ownership in PEN or GEHC? 88.9% of Penumbra shares are owned by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 4.2% of Penumbra shares are owned by company insiders. Comparatively, 0.3% of GE HealthCare Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more risk & volatility, PEN or GEHC? Penumbra has a beta of 0.53, suggesting that its share price is 47% less volatile than the S&P 500. Comparatively, GE HealthCare Technologies has a beta of 1.21, suggesting that its share price is 21% more volatile than the S&P 500. Do analysts rate PEN or GEHC? Penumbra presently has a consensus target price of $302.40, indicating a potential upside of 7.60%. GE HealthCare Technologies has a consensus target price of $88.27, indicating a potential upside of 22.86%. Given GE HealthCare Technologies' higher possible upside, analysts plainly believe GE HealthCare Technologies is more favorable than Penumbra.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Penumbra 0 Sell rating(s) 3 Hold rating(s) 13 Buy rating(s) 1 Strong Buy rating(s) 2.88GE HealthCare Technologies 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.83 Does the MarketBeat Community prefer PEN or GEHC? Penumbra received 808 more outperform votes than GE HealthCare Technologies when rated by MarketBeat users. Likewise, 80.36% of users gave Penumbra an outperform vote while only 62.00% of users gave GE HealthCare Technologies an outperform vote. CompanyUnderperformOutperformPenumbraOutperform Votes83980.36% Underperform Votes20519.64%GE HealthCare TechnologiesOutperform Votes3162.00% Underperform Votes1938.00% SummaryPenumbra and GE HealthCare Technologies tied by winning 9 of the 18 factors compared between the two stocks. Get Penumbra News Delivered to You Automatically Sign up to receive the latest news and ratings for PEN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PEN vs. The Competition Export to ExcelMetricPenumbraSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$10.88B$4.55B$5.42B$19.70BDividend YieldN/A43.65%5.22%3.84%P/E Ratio826.5929.8726.8335.13Price / Sales8.7871.50393.9034.12Price / Cash105.0151.0838.2517.51Price / Book9.416.346.874.78Net Income$90.95M$67.64M$3.22B$1.02B7 Day Performance-2.93%21.94%6.76%1.62%1 Month Performance3.88%26.54%13.66%13.00%1 Year Performance40.34%22.75%18.27%5.59% Penumbra Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PENPenumbra4.4338 of 5 stars$281.04-0.2%$302.40+7.6%+39.5%$10.88B$1.24B826.593,900Positive NewsGEHCGE HealthCare Technologies4.4781 of 5 stars$74.11+6.1%$88.27+19.1%-12.1%$33.93B$19.80B17.1250,000Positive NewsGap UpHigh Trading VolumePHGKoninklijke Philips2.427 of 5 stars$25.04+2.0%N/A-12.5%$23.53B$17.98B-29.8078,200News CoverageAnalyst DowngradeZBHZimmer Biomet4.8306 of 5 stars$98.18+3.1%$113.45+15.6%-20.1%$19.42B$7.70B22.0618,000Positive NewsSOLVSolventum1.2884 of 5 stars$74.85+6.6%$79.00+5.5%+20.4%$12.95B$8.25B27.2222,000Positive NewsAnalyst UpgradeSNNSmith & Nephew2.266 of 5 stars$28.43+0.3%$28.00-1.5%+12.9%$12.45B$5.81B13.1620,100News CoverageSTVNStevanato Group1.2604 of 5 stars€23.64-1.5%N/A+21.2%$7.16B$1.10B50.304,650Positive NewsGKOSGlaukos4.6737 of 5 stars$94.57+5.1%$134.67+42.4%-10.7%$5.40B$404.52M-32.95780News CoveragePositive NewsNARIInari Medical0.472 of 5 stars$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800News CoverageINSPInspire Medical Systems4.7118 of 5 stars$156.54+3.5%$211.91+35.4%-3.4%$4.62B$840.11M90.49760Positive NewsGap UpIRTCiRhythm Technologies1.3027 of 5 stars$137.80+0.1%$128.55-6.7%+52.5%$4.40B$618.59M-37.861,790Positive News Related Companies and Tools Related Companies GE HealthCare Technologies Competitors Koninklijke Philips Competitors Zimmer Biomet Competitors Solventum Competitors Smith & Nephew Competitors Stevanato Group Competitors Glaukos Competitors Inari Medical Competitors Inspire Medical Systems Competitors iRhythm Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:PEN) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Penumbra, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Penumbra With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PEN Stock Free PEN Stock Alerts